ORIGINAL RESEARCH article
Front. Neurol.
Sec. Stroke
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1651466
Efficacy of 3D Slicer-Assisted Minimally Invasive Thrombolysis Combined with Soft Channel Drainage versus Craniotomy: A Retrospective Study in Moderate Basal Ganglia Hemorrhage
Provisionally accepted- Department of Neurosurgery, Nanchong Central Hospital, Nanchong, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background The optimal clinical treatment strategy for moderate basal ganglia hemorrhage (30–50 ml) remains a subject of debate. This study aims to evaluate the clinical efficacy of 3D Slicer-assisted minimally invasive thrombolysis combined with soft channel drainage by comparing it with traditional craniotomy, thus assessing the clinical value of this minimally invasive approach. Methods In this retrospective study, the patients were divided into the minimally invasive group and the craniotomy group based on surgical approaches.The study compared operative time, hematoma clearance rates, and postoperative complication rates between the two groups. Functional recovery was assessed at 6 months postoperatively using the modified Rankin Scale (mRS) and Barthel Index. Additionally, the study analyzed differences in medical costs and cost-effectiveness between the two treatment approaches. Results A total of 112 patients were enrolled, with 41 in the minimally invasive group and 71 in the craniotomy group. Baseline characteristics showed no significant differences between groups (all P > 0.05), including demographics (e.g., sex: [30 males (73.2%) and 11 females (26.8%) vs. 51 males (71.8%) and 20 females (28.2%)], median age: [70 (63.5–76.5) years vs. 65 (58–72) years], median hematoma volume: [40.6 (37.7–47.8) mL vs. 41.2 (35.4–45.1) mL], median GCS score: [9 (8–11) vs. 10 (9–11)], and median NIHSS score: [15 (11.5–18) vs. 12 (10–18)]. Compared to the craniotomy group, the minimally invasive group exhibited significantly less intraoperative blood loss, shorter operative time, lower rates of tracheostomy and pulmonary infection (P < 0.05), and smaller volume of cerebral edema at 72 hours postoperatively (P < 0.05). Follow-up results 6 months postoperatively indicated that the minimally invasive group had significantly lower mRS scores and higher Barthel Index scores (P < 0.05). Regarding healthcare costs, expenses were lower in the minimally invasive group, and the incremental cost-effectiveness ratio (ICER) was more favorable (P < 0.05). Conclusions 3D Slicer-assisted minimally invasive thrombolysis combined with soft channel drainage represents an effective treatment for patients with moderate basal ganglia hemorrhage. It offers several advantages, including precise localization, minimal surgical trauma, a low complication rate, favorable safety profile, and cost-effectiveness.Therefore, this minimally invasive technique holds significant clinical value.
Keywords: 3D Slicer, Basal Ganglia Hemorrhage, Minimally Invasive Thrombolysis, Soft Channel Drainage, Craniotomy
Received: 21 Jun 2025; Accepted: 10 Oct 2025.
Copyright: © 2025 Chen, Tang, Shang, Luo, Qiao, He and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hua Xuan Chen, chxsslld@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.